Canurta's Journal

Categorised in: News

Canurta Inc., the pioneering company behind patent-pending technologies and formulations that fight inflammation at the source, presents ‘The Healing Project’, a collection of Utility NFTs that leverage IP and blockchain technology to advance the development of safe and natural solutions for chronic disease. “By pairing NFTs and health research, there is an exciting opportunity to…

Categorised in: News

Canurta Inc., the pioneering company behind patent-pending hemp technologies and formulations that are scientifically proven to target inflammation at the source, is pleased to announce the addition of University of Guelph researchers Dr. Kelly Boddington, Ph.D. and Dr. Eric Soubeyrand, Ph.D. to the team to scale up Canurta’s ability to biosynthetically produce rare hemp polyphenols….

Categorised in: News

Canurta Inc., the pioneering company behind patent-pending hemp technologies and formulations that targets inflammation at the source has formed a multi-year strategic partnership with Applied Pharmaceutical Innovation (API), a non-profit life sciences institute and Dr. Neal M. Davies, BSc(Pharm), PhD., R.Ph.FCAHS of University of Alberta’s Faculty of Pharmacy and Pharmaceutical Sciences and cofounder of API….

Categorised in: News

CanurtaTM, the pioneering brand behind patent-pending hemp technologies and formulations that fight inflammation at the source, is pleased to announce that Ethan Russo, MD, the preeminent global medical Cannabis expert, has joined the executive team as Senior Medical Advisor and will provide an exclusive license to related IP through his company CReDO Science, LLC. “Our…